Harbright 2026 VQ Biomedical Series, a series of Harbright LLC — Form D
Harbright 2026 VQ Biomedical Series, a series of Harbright LLC of CARY, NC, a pooled investment fund, filed a Form D exempt-offering notice with the SEC on 2026-07-08. The offering totals $1.0M, of which $597K was reported sold. Industry: Pooled Investment Fund.
Offering
- Filed: 2026-07-08
- Form: D
- Accession: 0002138549-26-000001
- Industry: Pooled Investment Fund
- Exemptions: 06b,3C,3C.1
- Total offering: $1.0M
- Amount sold: $597K
- Remaining: $403K
- Minimum investment: $10K
- Investors: 15
- Security types: fund interests
- Revenue range: Decline to Disclose
- SEC file number: 021-590029
Issuer
- Name: Harbright 2026 VQ Biomedical Series, a series of Harbright LLC
- CIK: 0002138549
- Entity type: Limited Liability Company
- Jurisdiction: DELAWARE
- Address: 107 KILMAYNE DRIVE SUITE B, CARY, NC, 27511
- Phone: 9193356001
Officers, directors & promoters (3)
| Name | Role | Location |
|---|
| John Michael Harlow | Related Person | Clayton, NC |
| John Powell Leachman | Related Person | Gainesville, GA |
| Robert Earl Ross | Related Person | Cary, NC |
More